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Abstract: Essential oils (EOs) are widely used in various industrial sectors but can present several 
instability problems when exposed to environmental factors. Encapsulation technologies are 
effective solutions to improve EOs properties and stability. Currently, the encapsulation in lipid 
nanoparticles has received significant attention, due to the several recognized advantages over 
conventional systems. The study aimed to investigate the influence of the lipid matrix composition 
and spray-drying process on the physicochemical properties of the lipid-based nanoparticles loaded 
with Lippia sidoides EO and their retention efficiency for the oil. The obtained spray-dried products 
were characterized by determination of flow properties (Carr Index: from 25.0% to 47.93%, and 
Hausner ratio: from 1.25 to 1.38), moisture (from 3.78% to 5.20%), water activity (<0.5), and powder 
morphology. Zeta potential, mean particle size and polydispersity index, of the redispersed dried 
product, fell between –25.9 mV and –30.9 mV, 525.3 nm and 1143 nm, and 0.425 and 0.652, 
respectively; showing slight differences with the results obtained prior to spray-drying (from –16.4 
mV to –31.6 mV; 147 nm to 1531 nm; and 0.459 to 0.729). Thymol retention in the dried products 
was significantly lower than the values determined for the liquid formulations and was affected by 
the drying of nanoparticles. 
Keywords: lipid nanoparticles; nanostructured lipid carriers; spray-drying; essential oil; Lippia 
sidoides; pepper rosemary 
 
1. Introduction 
Essential oils (EOs) are composed by volatile, natural, and complex hydrophobic compounds 
produced by the secondary metabolism of plants [1–5]. They represent a green alternative for diverse 
industrial sectors, such as pharmaceutical, food, cosmetics, health, agriculture, and livestock, given 
their proven biological activities as bactericidal, antiviral, fungicide, insecticidal, antioxidant, and 
other activities [6–14]. Nevertheless, EOs might present problems of instability when exposed to heat, 
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moisture, oxygen, and light. Besides, the reduced water solubility of EOs is another limitation for 
their incorporation in more elaborated products [15,16]. Encapsulation technologies represent an 
effective approach to preserve the physicochemical and biological properties of EOs. Their loading 
into nanoparticles enhances their stability against environmental factors, reduces their volatility, 
modulates the release, with the possibility to reduce toxicity and increase bioavailability [17,18].  
Encapsulation into lipid nanoparticles is receiving significant attention in the pharmaceutical 
and food sectors, as they offer several advantages, namely their biocompatibility, biodegradability 
and low toxicity, the possibility to encapsulate hydrophilic and lipophilic compounds, low 
production costs and easy scale-up [19–23]. Lipid nanoparticles are classified into different types 
produced by very different lipids and by different methods [24,25]. Among them, nanostructured 
lipid carriers (NLCs) receive special attention as, due to their solid matrix, they exhibit modified 
release profile and site-specific targeted delivery [26,27]. Besides, the presence of liquid lipid (oil) in 
their composition gives the additional advantage of enhanced drug-loading capacity [23]. As NLCs 
also have the capacity to load a range of nutraceuticals for oral administration [28], these particles 
hold a remarkable potential as a delivery system to build up the emerging area of the 
nanonutraceuticals with improved safety and efficacy [24,29,30]. 
In most situations, the production of a dried formulation from a liquid dispersion may be an 
advantage or even recommended to improve the stability of the payload [31–33]. A powdered 
product—obtained either from freeze-drying or spray-drying—exhibits higher shelf-life. To obtain a 
free-flowing powdered product, spray-drying is nevertheless more cost-effective then freeze-drying 
or lyophilization, as it is a faster drying process and is less expensive. Advantages such as the single-
stage method and the continuous progress of the process make this technique widely used in the 
industry [34]. Some studies report that the type of biomaterial, core–wall ratio, drying parameters, 
and storage conditions affect the microstructure of spray-dried microcapsules and the retention of 
the loaded drug. On the other hand, product microstructure affects the functionality, stability, and 
flow properties of the particles [35,36]. 
Lippia sidoides, belonging to the genus Lippia [37,38], is a typical herb species of Northeast Brazil 
widespread used in traditional medicine; it is known in Brazil as “alecrim-pimenta” (pepper-
rosemary). The main bioactive compounds in the EO of Lippia sidoides are monoterpenes, like thymol, 
p-cymene, myrcene, and the sesquiterpene, as caryophyllene [39–41]. These compounds are 
responsible for the biological properties of this EO, i.e., antimicrobial, antinociceptive, anti-
inflammatory, and antioxidant activities [42–44]. 
This study aimed at investigating the effects of the lipid matrix composition and drying process 
(spray-drying) on the thymol retention efficiency and on the physicochemical properties of the NLCs 
loaded with Lippia sidoides (pepper-rosemary) EO. 
2. Materials and Methods 
2.1. Material 
Lippia sidoides EO was purchased from PRONAT (Produtos Naturais do Nordeste LTDA, 
Horizonte, Ceará, Brazil). The constituents of the NLCs were Gelucire 50/13 (Gattefossé, Saint-Priest, 
France), oleic acid (LabSynth, Diadema, São Paulo, Brazil), Labrasol (Gattefossé, Saint-Priest, France), 
Span® 80 (Sigma-Aldrich, Darmstadt, Germany), Tween® 80 (LabSynth, Diadema, São Paulo, Brazil), 
and Poloxamer 188 (Kolliphor P 188 Micro, kindly donated by BASF, Ludwigshafen, Germany). 
Mixtures of whey protein (Arla Foods Ingredients S.A., Buenos Aires, Argentina), arabic gum 
(Nexira, São Paulo, Brazil), and colloidal silicon dioxide (Aerosil 200, Evonik Degussa, Essen, 
Germany) were used as spray-drying carriers. ultrapure water (Direct Q System, Millipore, Merck 
KGaA, Darmstadt, Germany) was used in the preparation of NLCs. Other chemicals and solvents 
used were of pharmaceutical or of high performance liquid chromatography (HPLC) grade. 
2.2. Characterization of the Major Constituents of the Lippia sidoides Essential Oil by Gas Chromatography  
coupled to Mass Spectrometry 
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The main constituents of Lippia sidoides EO were characterized by gas chromatography coupled 
to mass spectrometry (GC-MS Shimadzu QP-2010, Kyoto, Japan), using an DB-5 (30 m × 0.25 mm × 
0.25 µm) capillary column. The chromatographic conditions were based on previous study [19]. 
Hydrogen was used as the carrier gas, temperature-programmed from 60 °C to 240 °C with a ramp 
of 3 °C min-1. Other chromatographic conditions were as follows: injector temperature of 240 °C, H2 
with a flow rate of 1.30 mL/min as carrier gas, detector temperature of 260 °C, and split ratio 1:50. 
The constituents of the EO were identified by comparing the mass spectra obtained with those spectra 
published in the equipment database (Wiley electronic library or WILEY7.LIB) and by comparison 
with the Kovats index (IK), relative to a series of n-alkanes (C9-C20 [45]) with the ones reported by 
Adams [46]. 
2.3. Preparation of Nanostuctured Lipid Carriers 
Eight distinct NLC formulations were prepared according to Table 1, by the phase inversion 
method. Gelucire 50/13 plus the liquid lipids oleic acid or Labrasol comprised the lipid phase, and 
poloxamer 188 or a combination of Tween® 80:Span® 80 at a ratio 1:1 were added to the aqueous 
phase. Whey protein (P) and arabic gum (G) mixtures were used as drying carriers. Small amount of 
colloidal silicon dioxide (SiO2) was added only to emulsions having a high G:P ratio intending to 
improve drying performance. Gelucire and the liquid lipids were mixed and heated 10 °C above the 
Gelucire melting point (≈50 °C). The surfactants were dissolved in ultrapure water and heated to the 
same temperature of the lipid phase. The heated EO was slowly added to the lipid phase, under 
magnetic stirring. Finally, the aqueous phase was homogeneously dispersed into the lipid phase with 
EO by using a high-speed stirrer (Ultra Turrax T18, IKA, Wilmington, NC, USA) at 18,000 rpm/min 
for 2 min. The oil-in-water (O/W) emulsion formed was sonicated by an ultrasonic sonicator VCX-
750 (SONICS Vibracell, Newtown, CT, USA), with aid of 13 mm probe at a frequency of 20 kHz at an 
intensity of 70% for 2 min. Then, the drying carrier, previously hydrated was added. Solids 
concentration of formulations was 16.7% w/w for samples coded as A1 code and 21.4% w/w for A2 
code samples. 
Table 1. Constituents of nanostructured lipid carriers (NLCs) (%,w/w). 
Components Function 
Formulations 
F5A1 F6A1 F7A1 F8A1 F5A2 F6A2 F7A2 F8A2 
Lippia sidoides EO Bioactive  3.0 3.0 3.0 3.0 3.0 3.0 3.0 3.0 
Gelucire 50/13 
Amphiphilic 
solid lipid 
6.0 6.0 6.0 6.0 6.0 6.0 6.0 6.0 
Oleic acid Liquid lipid 1.0 1.0 - - 1.0 1.0 - - 
Labrasol Liquid lipid - - 1.0 1.0 - - 1.0 1.0 
Tween® 80 Surfactant 0.35 - 0.35 - 0.35 - 0.35 - 
Span® 80 Surfactant 0.35 - 0.35 - 0.35 - 0.35 - 
Poloxamer 188 Surfactant - 0.7 - 0.7 - 0.7 - 0.7 
Arabic gum Carrier 3.0 3.0 3.0 3.0 8.6 8.6 8.6 8.6 
Whey protein Carrier 3.0 3.0 3.0 3.0 1.1 1.1 1.1 1.1 
Aerosil 200 Carrier - - - - 1.1 1.1 1.1 1.1 
Water Solvent 83.3 83.3 83.3 83.3 121.5 121.5 121.5 121.5 
2.4. Spray-Drying and Drying Performance 
The resulting lipid-based systems loaded with Lippia sidoides EO were dried in a Lab-Plant SD-
05 spray dryer (Lab-Plant Ltd, Huddersfield, UK). Operating conditions were as follows: feed rate 4 
g/min, inlet temperature 100 °C for the formulations with A1 code and 90 °C for the formulations A2 
code, diameter of the atomizer nozzle 1 mm, drying gas flow rate 60 m3/h, and atomizing pressure 
and gas flow of 3 bar and 17 L min-1, respectively. The spray-drying performance was evaluated by 
determining the product recovery, calculated as the amount of powder collected from the dryer 
divided by the total amount of solids fed. Samples of the spray-dried powders were saved for the 
characterization of the physicochemical properties and quantification of thymol retention in HPLC. 
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2.5. Zeta Potential, Emulsion Size, and Polydispersity Index of the Liquid and Redispersed Dried Systems 
Zeta potential, particle size, and polydispersity index of the liquid and redispersed dried lipid 
systems were determined by dynamic light scattering (DLS) using a Zetasizer Nano–ZS90 (Malvern, 
UK). The dried samples were redispersed in ultrapure water at the same concentration of the liquid 
sample, stirred for 30 min, and diluted at a ratio of 1:200 (v/v) before the measurements. The 
measurements were made in triplicate. 
2.6. Flow Properties 
The flow properties of dried powders were assessed through the determination of Hausner Ratio 
(IHausner) and Carr’s Index (ICarr), according to Equations (1) and (2)Equation (1); Equation (2). 
 (1) 
 (2) 
where b is the freely bulk density (b = m0 V0-1), t,1250 is the tapped bulk density, determined using 
the volume occupied by the powder after tapping the probe 1250 times from a distance of 14.0 mm 
(USP, 2007) [47]. A Caleva Tapped Density Tester Type TDT (Frankfurt, Germany) was employed to 
measure bulk and tapped densities. 
2.7. Moisture Content and Water Activity 
The moisture content was determined immediately after drying by Karl Fischer titration, using 
100 mg of powder in a Karl Fischer 870 Titrino Plus Methrom (Herisau, Switzerland), calibrated with 
water before analysis. The water activity of the powders was determined in triplicate using an Aqua 
Lab 4Tev® water activity meter (Decagon Devices, Pullman, WA, USA) using the capacitance 
electrode. The measurements were made in triplicate, and the results expressed as mean and 
deviation. 
2.8. Thymol Retention of Nanostructured Lipid Carriers and Spray-Dried Product 
The GC-MS characterization of the Lippia sidoides EO confirmed thymol as the most abundant 
compound. Therefore, it was used as a marker to monitor the process development. High-
performance liquid chromatography with diode array detection (HPLC-DAD) was employed to 
monitor the concentration of thymol in the liquid and spray dried lipid systems. Chromatographic 
conditions were based on the method proposed by Leal et al. [48], with some modifications [49]. 
Analyses were performed in an HPLC Shimadzu Prominence LC-20A series and an LC-6A double 
pump (Shimadzu Corporation, Kyoto, Japan) using a C-18 column (Shimadzu Shim-Pack CLC(M) 
4.6 mm × 25 cm, 5 µm, 100 Å) at 30 °C. The mobile phase was a gradient of water (A) and acetonitrile 
(B). The acetonitrile concentration was changed as follows: 0–2 min, 10% B; 2–7 min, linear increase 
of B to 78%; 7–17 min, 78% B; 17– 20 min, linear increase of B to 100%; 20–23 min, 100% of B; 23–26 
min, linear decrease of B to 10%, 23–32 min, 10% of B. The chromatograms were recorded at 276 nm. 
The method of sample preparation consisted of diluting the samples in methanol, homogenize the 
mixture in the ultrasound bath and keep the solution under magnetic stirring for 30 min. After the 
extraction, the samples were centrifuged for 5 min at 5000 g. The supernatant was filtered through a 
membrane of 0.45 µm pore size, and 20 µL were injected in the chromatograph for quantification. 
2.9. Particle Morphology 
Photomicrographs of the spray dried-powder morphology were acquired by scanning electron 
microscopy with field emission gun (SEM-FEG). A small quantity of powder was mounted on stubs 
with double-sided adhesive carbon tape. Each sample was coated with platinum and analyzed in an 
Inspect F-50 (FEI, Eindhoven, The Netherlands) at 5 kV. 
b
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2.10. Statistical Analysis 
Statistical analysis was performed for some assays by using one-way ANOVA followed by 
Tukey’s post hoc test to determine if there are significant differences between the means.  
3. Results and Discussion 
The GC-MS results permitted the detection of twenty-seven compounds of the Lippia sidoides EO, 
and 26 were successfully identified (see Table 2), corresponding to 99.94% of the EO composition, as 
reported previously by us [19] and according to the equipment library. Thymol, the bioactive 
compound linked to most of the biological activities of Lippia sidoides [50], was confirmed as the most 
abundant component, with a concentration of 68.2%, as previously reported in the literature [51–53]. 
The benzene, 1-methyl-4-(1-methylethyl)- (9.43%), the trans-caryophyllene (7.72%), β-myrcene 
(2.84%), and the γ-terpinene (2.71%) are other main constituents of EO. Altogether, these five 
compounds reach 90.92% of the Lippia sidoides EO composition.  
Product recovery was the parameter used to evaluate the drying performance. The average 
value of product recovery measured for spray-dried products having the lower amount of drying 
carrier (small G:P ratio, A1 code) was 44.7 ± 2.0%; while average product recovery reached the value 
of 50.9 ± 3.4%, for the formulations with a high amount of drying carriers (high G:P ratio (A2 code). 
The stickiness of the atomized material to the spray-drying chamber was observed during all drying 
runs. Formulations with A1 code (spray-dried at 100 °C) exhibited high adhesion of the product to 
the drying chamber. For this reason, the spray-drying temperature was decreased to 90 °C to dry the 
formulations with A2 code, and a small amount of colloidal SiO2 was added (1%) to the drying 
carriers. Although a slight increase in product recovery was observed, the stickiness problems 
remained. According to Cortés-Rojas et al. [54], the stickiness of the powders to the drying equipment 
is one of the major causes of the product losses, especially when working with materials having low 
glass transition temperatures, as is the case of the lipid-based formulations. The analysis of the results 
did not evidence relevant differences in product recovery by changing lipids and surfactant systems 
in the formulations. 
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Table 2. Constitution of Lippia sidoides essential oil (EO) identified by gas chromatography coupled 
to mass spectrometry (GC-MS). 
Compoundsa Relative abundance (%)b KI ( - )c 
α-thujene 0.95 928 
Bicyclo[3.1.1]hept-2-ene, 2,6,6-trimethyl 0.56 937 
2-β-pinene 0.16 980 
β-myrcene 2.84 989 
1-phellandrene 0.07 1007 
E-β-ocimene 0.16 1011 
α-terpinene 1.16 1018 
Benzene, 1-methyl-4-(1-methylethyl)- 9.43 1025 
Bornylene 0.64 1032 
1.8-cineole 0.53 1033 
1,3,6-octatriene, 3,7-dimethyl-, (Z)- (CAS) 0.11 1037 
1,3,6-octatriene, 3,7-dimethyl-, (E)- (CAS) 0.16 1048 
γ-terpinene 2.71 1060 
Linalyl acetate 0.35 1099 
2-(chloromethyl)tetrahydropyran 0.15 1145 
Bicyclo[3.1.0]hex-3-en-2-one, 4-methyl- 0.26 1170 
3-cyclohexen-1-ol, 4-methyl-1-(1-methylethyl) 0.68 1180 
Thymol methyl ether 0.97 1231 
Thymol 68.22 1297 
α-copaene 0.34 1377 
trans-caryophyllene 7.72 1420 
Aromadendrene 0.46 1440 
α- Caryophyllene 0.34 1455 
Ledene 0.44 1493 
δ-cadinene 0.10 1520 
Caryophyllene oxide 0.43 1580 
a Compounds are listed in order of elution. b Relative abundance were calculated based on normalized 
MS peak areas, between the identified compounds. c KI: Kovats Index, a retention index relative to a 
series of alkanes (C10–C22). 
Zeta potential (Z), emulsion size (dp), and polydispersity index (PI) are important parameters 
generally used to characterize dispersed systems, including emulsions, solid lipid nanoparticles and 
nanostructured lipid carriers [21,22,55,56].  
Zeta potential (Z) characterizes the particle surface charges and thus provides information on 
the repulsive forces between particles and droplets. It is a very useful parameter for the assessment 
of the physical stability of colloidal dispersions. Generally, Z value more than +20 mV or less than –
20 mV promotes the repulsion of the particles from each other, predicting good physical stability of 
nanoparticle dispersion [20,57].  
Figure 1a–c shows respectively the comparison between the experimental values Zeta potential 
(Z), particle size (dp) and polydispersity index (PI) of the lipid-based systems, before and after spray-
drying (redispersed at same initial concentration). Z, dp and PI of the redispersed dried product falls 
between –25.9 mV and –30.9 mV, 525.3 nm to 1143 nm, and from 0.425 to 0.652, respectively; showing 
slight differences with the ones measured for liquid NLCs (from –16.4 mV to –31.6 mV; from 147 nm 
to 1531 nm; and from 0.459 to 0.729). Analyzing each formulation, in general, the zeta potential, 
particle size, and polydispersity index values are slightly higher in the dried form when compared 
to liquid composition. 
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Figure 1. Comparison between the experimental results of zeta potential (Z), emulsion size (dp), and 
polydispersity index (PI) of the liquid and redispersed dried lipid systems, (a) to (c), respectively. 
Same letters/numbers indicate a statistically significant difference (Tukey’s post-test, p ≤ 0.05). 
One-way variance analysis followed by Tukey’s post hoc test was carried out for the 
experimental results in order to verify statistically significant differences due to encapsulating 
formulation constituents and drying. 
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The ANOVA of the data from Figure 1a indicates that the changing the surfactant system from 
Tween® 80:Span® 80 (hydrophilic-lipophilic balance of 9.7) to Poloxamer 188 (hydrophilic-lipophilic 
balance ≈ 29.0), although their distinct physicochemical properties, did not evidence significant effect 
on the zeta potential both for the liquid and spray dried redispersed samples. This behavior can be 
attributed to the small percentage of these compounds regarding the other lipids and drying carriers 
used and by the similar HLB presented after their respective mixtures with Gelucire. On the other 
hand, the type of liquid lipid affects significantly the zeta potential of the NLCs. Formulations 
containing Labrasol showed smaller values of zeta potential, independent of the drying carrier 
systems used. The differences encountered in the zeta potential values between oleic acid versus 
Labrasol based NLC may also be attributed to the different capacity of these latter in solubilizing the 
essential oil. Considering that essential oil has been dissolved within 30 min stirring, Labrasol may 
have a lower solubilizing capacity than oleic acid. 
For the redispersed spray-dried powders, the reduction on zeta potential was only verified for 
the sample containing the drying carrier with a higher G:P ratio (p ≤ 0.05). Nevertheless, for the 
redispersed powders, the comparisons are trickier, since other factors such as the degree of product 
redispersion and the EO retention as well, affects the zeta potential results. Indeed, compared with 
the blank system, the addition of EO causes a significant reduction in zeta potential. Therefore, the 
distinct values of EO retention in the spray-dried powders, undoubtedly affect the experimental 
values of zeta potential. 
Concerning the drying carriers’ systems, there are significant differences between the zeta 
potential determined for both systems (coded as A1 and A2). For NLCs containing oleic acid, a slight 
increase in zeta potential might be verified with the increasing the G:P ratio (and consequently solids 
content – A2 code samples) of the drying carrier systems. A different behavior could be seen for NLCs 
containing Labrasol. For redispersed spray-dried products, most of the samples did not evidence a 
statistically significant effect of the drying carrier system. Again, the results for dried powders are 
more difficult to analyze, since differences of the EO loaded in the product and the redispersing 
operation would affect in any way the measured results.  
By comparing the experimental values of zeta potential of the original and redispersed spray-
dried products, no differences are verified for the formulations containing oleic acid, independent of 
other factors. However, significant increase due to the spray-drying process can be observed by those 
containing Labrasol.  
In summary, considering the zeta potential analyses, it can be supposed that the system 
containing oleic acid is more stable compared to Labrasol. From the technological point of view, all 
the systems were considered stable, not showing any kind of instability during accelerating stability 
testing of the NLCs . 
Figure 1b shows that the spray-dried powders exhibited particle sizes in the nanoscale range, 
with the exception of both F8 formulations. Larger particle sizes were exhibited for Labrasol 
containing formulations comparatively to the ones composed by oleic acid, independent of the drying 
carrier system used (p ≤ 0.05). This behavior was observed for both liquid and spray dried products. 
The changing in the surfactant systems added to the formulations (Tween® 80:Span® 80 or Poloxamer 
188), presented significant effect only for the Labrasol-containing formulations, for the drying carrier 
system with low G:P ratio, as can be seen in Figure 1b.  
In general, the increase of the G:P ratio (and solid contents as well) leads to a bigger particle size. 
These effects were evident for NLCs, although they were not observed for the redispersed spray-
dried products. We speculate that NLCs should present a smaller droplet diameter compared to the 
redispersed spray-dried powders. This behavior is observed for almost of the data shown in Figure 
1b, except for F7A1 and 7A2, which exhibited an unpredicted behavior. 
The polydispersity index (PI) indicates the width of the particle size distribution, which ranges 
from 0 to 1. Theoretically, monodisperse populations exhibit PI = 0 [58–60]. According to Maitani et 
at. [61], a polydispersity index value greater than 0.3 shows a high degree of heterogeneity. In this 
work, the PI values obtained were around 0.5, indicating particles with a slight heterogeneous 
distribution. In this work, the formulation variables and spray-drying did not show statistically 
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significant effects on PI. The unique exception was observed for the formulations F6A1 and FA62, 
where an increase in PI was observed by increasing the G:P ratio (and solids content) of the drying 
carrier. 
The experimental results of the moisture content, water activity, bulk and tapped powders 
densities (b and t,1250), IHausner, and ICarr of the spray-dried powders are presented in Table 3. 
Table 3. Properties of the spray-dried powders. 
Form 
Moisture content 
(%) 
Water activity 
(-) 
b 
(g cm-3) 
t,1250 
(g cm-3) 
IHausner 
(-) 
ICarr 
(-) 
F5A1 3.78 ± 0.05 - 0.13 0.17 1.32 32.00 
F6A1 4.05 ± 0.03 - 0.13 0.17 1.31 30.77 
F7A1 4.21 ± 0.08 - 0.13 0.18 1.35 34.62 
F8A1 4.42 ± 0.07 - 0.15 0.19 1.27 26.67 
F5A2 4.45 ± 0.27 0.366 ± 0.011 0.17 0.22 1.33 33.33 
F6A2 5.20 ± 0.08 0.421 ± 0.002 0.15 0.21 1.38 37.93 
F7A2 4.40 ± 0.27 0.353 ± 0.011 0.17 0.23 1.34 33.93 
F8A2 4.73 ± 0.02 0.353 ± 0.008 0.19 0.24 1.25 25.00 
 
Moisture content and water activity are parameters related to the composition of the 
formulations and drying conditions employed [54,62,63]. Moisture content is related to the total 
quantity of water in the dried system [64]. Water activity and moisture content are optimally present 
for the stability and safety limit of the product. Although the statistical analyses of the experimental 
results of product moisture content showed some significant effects due to changing formulation 
parameters namely surfactant systems, liquid lipids, and drying carriers’ mixture, the differences 
observed are not technological relevant. The measured results ranged from 3.78% to 5.20%, which 
are adequate to ensure product quality. The water activity of dried powders is a more pertinent factor 
than the moisture content. It is linked to the amount of free water content available for microbial 
growth and other product degradation reactions. Although factors such as storage temperature and 
pH can affect the growth of spoilage microorganisms and food-borne pathogens, the water activity 
is generally recognized as being most important [65]. The water activity may vary between 0 and 1, 
and higher values imply a great amount of water available for physicochemical degradation reactions 
and microbial growth. Water activity values below 0.5, prevent microbial growth [66]. The water 
activity was not measured for the powders with A1 code, but all the values obtained for the A2 
powders were below the safety limit of 0.5. 
The flow parameters, IHausner and ICarr, were calculated from the experimental values of tapped 
and bulk densities of spray-dried powders. IHausner and ICarr are factors commonly used as an indirect 
measure of particle flowability. Both are based on the friction and accommodation of the particles, 
which in turn are influenced by the physicochemical parameters of the particles, such as size and 
surface properties. Low IHausner and ICarr values indicate low cohesiveness, therefore better flow [54]. 
Powders presenting low friction between the particles, such as large particles, have an IHausner around 
1.2, whereas values higher than 1.6 are presented by smaller and cohesive particles with restricting 
flow. Materials with ICarr between 5% and 15% are assumed of excellent fluidity; from 12% to 16% 
good flow; from 18% to 21% scarce; from 22% to 35% weak flow; from 35 to 38% very weak; and 
higher than 40% extremely weak flow. Results presented in Table 3 show that the dried products 
presented weak and very weak flow, usual for spray-dried powders, normally linked to the small 
powder particle diameters obtained. The samples composed by Labrasol and Poloxamer 188 (F8A1 
and F8A2) exhibited better flow properties. It is concluded that the flow properties have an inversely 
proportional relationship with the diameter of the particles since these were also the samples for 
which the particles showed the largest size. 
The volatiles retention is governed by factors linked to the physicochemical properties of the 
volatile compound, the constituents of NLC, the drying carriers (wall material), and drying 
conditions [53,67,68]. It is well known in the literature that high total solids content in the 
encapsulating emulsions are beneficial to volatile retention [35,53]. It can be explained because high 
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volatilities, at low concentrations, tend to evaporate much faster from aqueous solutions than water 
does. However, if the solution or suspension concentration is sufficiently high, the reverse is 
generally true [69]. This trend was also observed in the results obtained for thymol retention (Figure 
2). The samples added with the carrier system having a higher G:P ratio, and also higher total solid 
content (A2) showed a remarkable increase of thymol retention compared to the formulations with a 
small G:P ratio (A1). This fact is justified, since the diffusivities of the compounds through the wall, 
at higher solids content, should be lower [54,70]. On the other hand, the retention efficiencies for the 
NLCs were significantly higher than the spray-dried powders, showing values higher than 82%. One 
possible explanation for the high losses of EO in the dried product is probably associated with the 
small size of the lipid-based formulations droplets (nanoscale range), which increased significantly 
the surface area in contact with the spray-drying gas, favoring the evaporation of volatile compounds. 
Maybe the use of a more product friendly drying process, e.g., freeze-drying, would improve 
retention of volatiles in the dried powders. Besides the increase of the concentration of lipid materials 
would result in either the increase of the number of NLCs or their mean size, which could certainly 
contribute to the increase of the EO retention in the lipid matrices. However, the increase of NLCs 
concentration and/or mean size could increase the risk of particle aggregation during the spray-
drying process. 
 
Figure 2. Retention of thymol in the spray dried product. Percentage relative to the initial 
concentration of thymol in essential oil. 
The morphology of the spray-dried particles is affected by factors as the drying kinetics and the 
constituents of the feed formulation [54]. Both the physical and chemical nature of the material being 
spray dried are important in determining its drying behavior and particle morphology [69]. The 
morphological appearance of the spray-dried particles (Figure 3) was found to have a round shape, 
heterogeneous size, and external surface with shriveled aspect, typical of spray-dried microcapsules 
[71] and very well consistent with previous studies [54,72]. With respect to the composition of the 
formulations, no significant difference could be observed in the particles’ morphology.  
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Figure 3. Typical morphology of spray-dried lipid-based formulations: F7A1 (A); F7A2 (B). 
4. Conclusions 
The results here reported show that the encapsulation of Lippia sidoides EO in NLCs is a feasible 
technology. These results are relevant indicating possible applications within the new area of the 
nutraceutical science [23,73–75]: nano nutraceuticals are a great challenge for the future, assuring 
their nutraceutical value at a nano-level as well as safety and efficacy [24,29,30]. The spray-drying of 
these lipid systems is promising, although demanding due to high product stickiness to the dryer 
(due the low melting point and also the glass transition temperatures), and losses of EO (low retention 
efficiency), exceeding 80% in some experimental runs. The samples added with the carrier system 
having a higher G:P ratio (and also higher total solid content—A2) showed a remarkable increase of 
thymol retention compared to the formulations with a small G:P ratio (A1). The differences between 
the physicochemical properties of the liquid formulations and redispersed dried products were not 
remarkable. The zeta potential and particle size of the liquid and redispersed dried product suffer 
effects of lipid matrix composition and drying carrier system, ranging from –16.4 mV to –31.6 mV 
and from 147 nm to 1531 nm; and from –25.9 mV to –30.9 mV, and from 525.3 nm to 1143 nm, 
respectively. The dried product present values of moisture content (from 3.78% to 5.20%) and water 
activity (<0.5) adequate to guarantee product stability. Furthermore, the powders presented low 
densities and exhibited IHausner (from 1.25 to 1.38), and ICarr (from 25.0% to 37.93%), characteristic of 
weak and very weak flow. The dried product was promptly re-dispersible in water, returning its 
original consistency after adding water, which is an outstanding advantage, although optimization 
of EO load is still required. 
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